XML 98 R79.htm IDEA: XBRL DOCUMENT v3.3.1.900
16. Peoples Bancorp of North Carolina, Inc. (Parent Company Only) Condensed Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Assets                          
Interest-bearing time deposit                       $ 10,569 $ 17,885
Investment securities available for sale                       268,530 281,099
Total assets                       1,038,481 1,040,494
Liabilities and Shareholders' Equity                          
Junior subordinated debentures                       20,619 20,619
Liabilities                       933,617 941,829
Shareholders' equity                       104,864 98,665
Total liabilities and shareholders' equity                       1,038,481 1,040,494
Revenues:                          
Interest and dividend income $ 9,961 $ 9,947 $ 9,191 $ 9,567 $ 9,716 $ 9,583 $ 9,576 $ 9,545 $ 38,666 $ 38,420 $ 36,696    
Expenses:                          
Interest 851 874 875 884 1,015 1,076 1,085 1,111 3,484 4,287 5,353    
Income/(Loss) before income tax benefit and equity in undistributed earnings of subsidiaries 2,801 3,435 3,490 3,007 1,440 2,917 3,467 3,501 12,733 11,325 8,570    
Income tax benefit 613 942 866 679 (377) 475 916 923 3,100 1,937 1,879    
Net earnings 2,188 2,493 2,624 2,328 1,817 2,442 2,551 2,578 9,633 9,388 6,691    
Cash flows from operating activities:                          
Net earnings 2,188 $ 2,493 $ 2,624 2,328 1,817 $ 2,442 $ 2,551 2,578 9,633 9,388 6,691    
Change in:                          
Other assets                 165 (778) 1,508    
Net cash provided (used by) operating activities                 13,863 14,441 24,921    
Cash flows from investing activities:                          
Purchases of investment securities available for sale                 (19,220) (32,851) (98,129)    
Proceeds from maturities of investment securities available for sale                 5,475 36,148 63,597    
Net cash used by investing activities                 (30,126) (11,898) (19,234)    
Cash flows from financing activities:                          
Cash dividends paid on Series A preferred stock                 0 0 (734)    
Proceeds from exercise of stock options                 0 37 0    
Net cash (used) provided by financing activities                 (13,072) (10,218) 22,243    
Net change in cash and cash equivalents                 (29,335) (7,675) 27,930    
Noncash investing and financing activities:                          
Change in unrealized gain on investment securities available for sale, net                 57 6,625 (6,784)    
Accrued redemption of Series A Preferred Stock                 0 0 12,632    
Parent Company                          
Assets                          
Cash 558     745 745     12,879 745 745 12,879 558 745
Interest-bearing time deposit                       1,000 1,000
Investment in subsidiaries                       121,848 115,457
Investment in PEBK Capital Trust II                       619 619
Investment securities available for sale                       1,234 1,235
Other assets                       244 245
Total assets                       125,503 119,301
Liabilities and Shareholders' Equity                          
Junior subordinated debentures                       20,619 20,619
Liabilities                       20 17
Shareholders' equity                       104,864 98,665
Total liabilities and shareholders' equity                       $ 125,503 $ 119,301
Revenues:                          
Interest and dividend income                 3,979 2,718 13,576    
Total revenues                 3,979 2,718 13,576    
Expenses:                          
Interest                 403 389 398    
Other operating expenses                 538 527 159    
Total expenses                 941 916 557    
Income/(Loss) before income tax benefit and equity in undistributed earnings of subsidiaries                 3,038 1,802 13,019    
Income tax benefit                 262 239 84    
Income/(Loss) before equity in undistributed earnings of subsidiaries                 3,300 2,041 13,103    
Equity in undistributed earnings (loss) of subsidiaries                 6,333 7,347 (6,412)    
Net earnings                 9,633 9,388 6,691    
Cash flows from operating activities:                          
Net earnings                 9,633 9,388 6,691    
Adjustments to reconcile net earnings to net cash provided by operating activities:                          
Equity in undistributed earnings of subsidiaries                 (6,333) (7,347) 6,412    
Change in:                          
Other assets                 1 28 (73)    
Accrued income                 0 (5) 0    
Accrued expense                 3 1 27    
Other liabilities                 0 (108) 108    
Net cash provided (used by) operating activities                 3,304 1,957 13,165    
Cash flows from investing activities:                          
Proceeds from maturities of investment securities available for sale                 0 500 1    
Net change in interest-bearing time deposit                 0 (1,000) 800    
Net cash used by investing activities                 0 (500) 801    
Cash flows from financing activities:                          
Cash dividends paid on Series A preferred stock                 0 0 (734)    
Cash dividends paid on common stock                 (1,574) (1,022) (677)    
Preferred stock and warrant repurchase                 0 (12,524) 0    
Stock repurchase                 (1,917) (82) 0    
Proceeds from exercise of stock options                 0 37 0    
Net cash (used) provided by financing activities                 (3,491) (13,591) (1,411)    
Net change in cash and cash equivalents                 (187) (12,134) 12,555    
Cash at beginning of year       $ 745       $ 12,879 745 12,879 324    
Cash at end of year $ 558       $ 745       558 745 12,879    
Noncash investing and financing activities:                          
Change in unrealized gain on investment securities available for sale, net                 1 8 77    
Accrued redemption of Series A Preferred Stock                 $ 0 $ 0 $ 12,632